Menu

5 min read

New real-world data adds to a growing body of MenaQ7® research about children’s growth

Published on
November 10, 2026
New Real-World Data Adds to a Growing Body of MenaQ7® Research about Children's growth

    Interest in Vitamin K2 for children’s growth is still on the trend. A recent published study in Nutrients (Nguyen et al., 2026) is the third to examine growth outcomes in children with finished products featuring MenaQ7®, the Vitamin K2 (MK-7).

     

    Conducted in Vietnam between March 2022 and June 2025, this retrospective, longitudinal, observational study followed 1,150 healthy children aged 6 to 14 years. 537 children received MenaQ7® at 360 µg/day, taken continuously from the start of the study, for a follow-up period ranging from a few months to 30 months. 613 children served as controls.

     

    A growing body of evidence

    Children taking a multinutrient supplement containing MenaQ7® vitamin K2 MK-7 continuously gained more height over time. The longer the follow-up, the clearer the association became.

    Among children followed for more than 12 months, those in the vitamin K2 MK-7 group gained on average about 1.85 cm more than the controls: +9.88 cm versus +8.03 cm (p<0.001).

     

    This study builds upon previous research involving MenaQ7®:

    • A study of 945 children aged 1 to 14 years found that continuous MenaQ7® supplementation (180-360 µg/day) was associated with improved height growth, with the strongest association in children aged 1 to 5 years.
    • A nationwide study of 43,505 children aged 6 to 17 years found that children taking Vitamin K2 daily, including finished products with MenaQ7®, had 18% lower odds of impaired growth compared to those who did not.

     

    Different designs, different populations, different age groups, and one common thread: MenaQ7® featured in every study. This growing body of research is a strong signal of the value of regular, long-term use for brands developing children’s products.

    Discover MenaQ7®

    MenaQ7® is the only clinically proven vitamin K2 as MK-7 for bone and heart health. With 22+ clinical studies that prove safe and effective health benefits, MenaQ7® offers the highest quality and sustainability commitments with the purest Vitamin K2 molecule derived from natural fermentation in our European manufacturing site.

    Formulate even under the harshest conditions of supplement & food processing with MenaQ7® Matrix, the Natural Choice for stable and protected Vitamin K2.

    MenaQ7®’s ironclad quality, science & versatile portfolio provides you flexibility and concept opportunities when developing your new product and gives you the confidence that it will gain attention on crowded shelves.

    Realted News